119 related articles for article (PubMed ID: 16231716)
1. Neurohormonal and circulatory effects of short-term treatment with enalapril and quinapril in dogs with asymptomatic mitral regurgitation.
Moesgaard SG; Pedersen LG; Teerlink T; Häggström J; Pedersen HD
J Vet Intern Med; 2005; 19(5):712-9. PubMed ID: 16231716
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of enalapril for prevention of congestive heart failure in dogs with myxomatous valve disease and asymptomatic mitral regurgitation.
Kvart C; Häggström J; Pedersen HD; Hansson K; Eriksson A; Järvinen AK; Tidholm A; Bsenko K; Ahlgren E; Ilves M; Ablad B; Falk T; Bjerkfås E; Gundler S; Lord P; Wegeland G; Adolfsson E; Corfitzen J
J Vet Intern Med; 2002; 16(1):80-8. PubMed ID: 11822810
[TBL] [Abstract][Full Text] [Related]
3. Decreased sympathetic tone after short-term treatment with enalapril in dogs with mild chronic mitral valve disease.
Chompoosan C; Buranakarl C; Chaiyabutr N; Chansaisakorn W
Res Vet Sci; 2014 Apr; 96(2):347-54. PubMed ID: 24559801
[TBL] [Abstract][Full Text] [Related]
4. Decreased plasma concentration of nitric oxide metabolites in dogs with untreated mitral regurgitation.
Pedersen HD; Schütt T; Søndergaard R; Qvortrup K; Olsen LH; Kristensen AT
J Vet Intern Med; 2003; 17(2):178-84. PubMed ID: 12683618
[TBL] [Abstract][Full Text] [Related]
5. The effect of angiotensin-converting enzyme inhibitors of left atrial pressure in dogs with mitral valve regurgitation.
Ishikawa T; Tanaka R; Suzuki S; Miyaishi Y; Akagi H; Iino Y; Fukushima R; Yamane Y
J Vet Intern Med; 2010; 24(2):342-7. PubMed ID: 20102507
[TBL] [Abstract][Full Text] [Related]
6. Effects of long-term treatment with enalapril or hydralazine on the renin-angiotensin-aldosterone system and fluid balance in dogs with naturally acquired mitral valve regurgitation.
Häggström J; Hansson K; Karlberg BE; Kvart C; Madej A; Olsson K
Am J Vet Res; 1996 Nov; 57(11):1645-52. PubMed ID: 8915446
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of mitral valve insufficiency in dogs with the ACE inhibitor enalapril. A clinical progress study].
Biller B; Hörauf A; Kraft W
Tierarztl Prax Ausg K Kleintiere Heimtiere; 1998 Feb; 26(1):21-30. PubMed ID: 9531670
[TBL] [Abstract][Full Text] [Related]
8. Acute and short-term hemodynamic, echocardiographic, and clinical effects of enalapril maleate in dogs with naturally acquired heart failure: results of the Invasive Multicenter PROspective Veterinary Evaluation of Enalapril study. The IMPROVE Study Group.
J Vet Intern Med; 1995; 9(4):234-42. PubMed ID: 8523320
[TBL] [Abstract][Full Text] [Related]
9. Effects of naturally acquired decompensated mitral valve regurgitation on the renin-angiotensin-aldosterone system and atrial natriuretic peptide concentration in dogs.
Häggström J; Hansson K; Kvart C; Karlberg BE; Vuolteenaho O; Olsson K
Am J Vet Res; 1997 Jan; 58(1):77-82. PubMed ID: 8989501
[TBL] [Abstract][Full Text] [Related]
10. Body size, but neither age nor asymptomatic mitral regurgitation, influences plasma concentrations of dimethylarginines in dogs.
Pedersen LG; Tarnow I; Olsen LH; Teerlink T; Pedersen HD
Res Vet Sci; 2006 Jun; 80(3):336-42. PubMed ID: 16182327
[TBL] [Abstract][Full Text] [Related]
11. Results of the veterinary enalapril trial to prove reduction in onset of heart failure in dogs chronically treated with enalapril alone for compensated, naturally occurring mitral valve insufficiency.
Atkins CE; Keene BW; Brown WA; Coats JR; Crawford MA; DeFrancesco TC; Edwards NJ; Fox PR; Lehmkuhl LB; Luethy MW; Meurs KM; Petrie JP; Pipers FS; Rosenthal SL; Sidley JA; Straus JH
J Am Vet Med Assoc; 2007 Oct; 231(7):1061-9. PubMed ID: 17916031
[TBL] [Abstract][Full Text] [Related]
12. [ACE inhibitors in dogs with subclinical chronic mitral insufficiency].
Kvart C; Häggström J; Pedersen HD
Tijdschr Diergeneeskd; 2003 Feb; 128(3):76-7. PubMed ID: 12616901
[No Abstract] [Full Text] [Related]
13. Hemodynamic and morphologic changes after long-term angiotensin converting enzyme inhibition in patients with chronic valvular regurgitation.
Schön HR
J Hypertens Suppl; 1994 Jul; 12(4):S95-104. PubMed ID: 7965280
[TBL] [Abstract][Full Text] [Related]
14. Increased NT-proANP predicts risk of congestive heart failure in Cavalier King Charles spaniels with mitral regurgitation caused by myxomatous valve disease.
Eriksson AS; Häggström J; Pedersen HD; Hansson K; Järvinen AK; Haukka J; Kvart C
J Vet Cardiol; 2014 Sep; 16(3):141-54. PubMed ID: 25130405
[TBL] [Abstract][Full Text] [Related]
15. R-R interval variations influence the degree of mitral regurgitation in dogs with myxomatous mitral valve disease.
Reimann MJ; Møller JE; Häggström J; Markussen B; Holen AE; Falk T; Olsen LH
Vet J; 2014 Mar; 199(3):348-54. PubMed ID: 24507881
[TBL] [Abstract][Full Text] [Related]
16. Effects of enalapril maleate on survival of dogs with naturally acquired heart failure. The Long-Term Investigation of Veterinary Enalapril (LIVE) Study Group.
Ettinger SJ; Benitz AM; Ericsson GF; Cifelli S; Jernigan AD; Longhofer SL; Trimboli W; Hanson PD
J Am Vet Med Assoc; 1998 Dec; 213(11):1573-7. PubMed ID: 9838955
[TBL] [Abstract][Full Text] [Related]
17. Controlled clinical evaluation of enalapril in dogs with heart failure: results of the Cooperative Veterinary Enalapril Study Group. The COVE Study Group.
J Vet Intern Med; 1995; 9(4):243-52. PubMed ID: 8523321
[TBL] [Abstract][Full Text] [Related]
18. Flow-mediated vasodilation measurements in Cavalier King Charles Spaniels with increasing severity of myxomatous mitral valve disease.
Moesgaard SG; Klostergaard C; Zois NE; Teerlink T; Molin M; Falk T; Rasmussen CE; Luis Fuentes V; Jones ID; Olsen LH
J Vet Intern Med; 2012; 26(1):61-8. PubMed ID: 22151409
[TBL] [Abstract][Full Text] [Related]
19. Assessment of changes in hemostatic markers in Cavalier King Charles Spaniels with myxomatous mitral valve disease.
Tarnow I; Kristensen AT; Olsen LH; Pedersen HD
Am J Vet Res; 2004 Dec; 65(12):1644-52. PubMed ID: 15631028
[TBL] [Abstract][Full Text] [Related]
20. Long-term angiotensin-converting enzyme inhibition reduces plasma asymmetric dimethylarginine and improves endothelial nitric oxide bioavailability and coronary microvascular function in patients with syndrome X.
Chen JW; Hsu NW; Wu TC; Lin SJ; Chang MS
Am J Cardiol; 2002 Nov; 90(9):974-82. PubMed ID: 12398965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
